Impact of new pill to treat postpartum depression will depend on price

By Axios
| August 08, 2023

The approval of the first-ever pill treating postpartum depression on Friday was hailed as a significant milestone, but it was quickly tempered by questions around how much the drug will cost.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...